Supernus Pharmaceuticals shares owned by Ashford Capital Management
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Ashford Capital Management
from 13F filings
Historical chart of Ashford Capital Management investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Ashford Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by Ashford Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $24M | 827k | 28.94 |
| 2023-09-30 | $25M | 917k | 27.57 |
| 2023-06-30 | $28M | 926k | 30.06 |
| 2023-03-31 | $33M | 922k | 36.23 |
| 2022-12-31 | $33M | 934k | 35.67 |
| 2022-09-30 | $37M | 1.1M | 33.85 |
| 2022-06-30 | $33M | 1.1M | 28.92 |
| 2022-03-31 | $36M | 1.1M | 32.32 |
| 2021-12-31 | $31M | 1.1M | 29.16 |
| 2021-09-30 | $27M | 1.0M | 26.67 |
| 2021-06-30 | $31M | 1.0M | 30.79 |
| 2021-03-31 | $32M | 1.2M | 26.18 |
| 2020-12-31 | $31M | 1.2M | 25.16 |
| 2020-09-30 | $17M | 818k | 20.84 |
| 2020-06-30 | $16M | 687k | 23.75 |
| 2020-03-31 | $10M | 576k | 17.99 |
| 2019-12-31 | $16M | 693k | 23.72 |
| 2019-09-30 | $22M | 804k | 27.48 |
| 2019-06-30 | $28M | 834k | 33.09 |
| 2019-03-31 | $29M | 837k | 35.04 |
| 2018-12-31 | $25M | 750k | 33.22 |
| 2018-09-30 | $35M | 699k | 50.35 |
| 2018-06-30 | $42M | 699k | 59.85 |
| 2018-03-31 | $40M | 881k | 45.80 |
| 2017-12-31 | $30M | 756k | 39.85 |
| 2017-09-30 | $30M | 754k | 40.00 |
| 2017-06-30 | $33M | 756k | 43.10 |
| 2017-03-31 | $23M | 745k | 31.30 |
| 2016-12-31 | $16M | 643k | 25.25 |
| 2016-09-30 | $16M | 643k | 24.73 |
| 2016-06-30 | $13M | 643k | 20.37 |
| 2016-03-31 | $8.6M | 562k | 15.25 |
| 2015-12-31 | $6.8M | 509k | 13.44 |
| 2015-09-30 | $7.2M | 511k | 14.03 |
| 2015-06-30 | $12M | 712k | 16.98 |
| 2015-03-31 | $8.2M | 680k | 12.09 |
| 2014-12-31 | $3.5M | 418k | 8.30 |
More positions owned by Ashford Capital Management
View all positions for Ashford Capital Management